Giving a single dose of preventative antibiotics after assisted childbirth could prevent almost half of maternal infections and also reduce antibiotic use by infection prevention, according to a new trial.
A new anaerobic organ-on-a-chip model has been demonstrated to support a complex community of gut microbes under low-oxygen conditions. This model of the microbiome could open opportunities for drug testing and development.
Delivering HIV vaccines via slow-release methods has enhanced the protective immune response in preclinical models, according to new research.
Phage therapy using genetically engineered bacteriophages has treated a 15-year-old girl who developed a drug-resistant infection following a lung transplant, as outlined in Nature Medicine.
New research has suggested that a combination treatment of gentamicin with azithromycin was almost as effective as the currently used ceftriaxone for treating genital gonorrhea.
Take a look at this month’s industry headlines including news from ViiV Healthcare on long-acting and single dose formulations, sales for Eli Lilly and the possible development of a plague vaccine.
International organizations have united on critical recommendations to combat antimicrobial resistance in a ground-breaking report released today.
Long durations of antibiotic use in middle- and late-adulthood have been linked to an increased risk of cardiovascular events in new research studying over 36,000 women.
A large-scale trial of RTS,S – the world’s first malaria vaccine to provide partial protection – is due to commence in Malawi, Kenya and Ghana.